Key clinical point: Men with HIV are likely prone to the same cardiovascular risks from testosterone therapy as other men.
Major finding: The risk of significant coronary artery calcium progression was 2.0 times greater among continuous users and 2.4 times greater among new users, compared with former users.
Study details: A review of 300 men who have sex with men
Disclosures: The work was funded by the National Institutes of Health. The lead investigator didn't report any disclosures.
Haberlen S et al. CROI 2020, Abstract 662.